5 Most Promising Long-Term Stocks According to Analysts

2. Evolus, Inc. (NASDAQ:EOLS)

Average Analyst Share Price Target Percentage Upside: 97.76%

Average Share Price Target: $20.29

Evolus, Inc. (NASDAQ:EOLS) is a medical company that specializes in selling products used in aesthetics and beauty applications. Its shares are rated Strong Buy on average and the average share price target is $20.29.

For their third quarter of 2023 shareholdings, 23 out of the 910 hedge funds covered by Insider Monkey had held a stake in the company. Evolus, Inc. (NASDAQ:EOLS)’s largest hedge fund investor is Timothy P. Lynch’s Stonepine Capital due to its $47.3 million stake.

Follow Evolus Inc.